CytoSorbents Corp. (CTSO)
6.01
+0.66
(+12.34%)
USD |
NASDAQ |
Oct 22, 16:00
5.71
-0.30
(-4.99%)
After-Hours: 05:38
CytoSorbents EPS Diluted (Quarterly) : -1.407 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.407 |
| March 31, 2026 | -1.635 |
| December 31, 2025 | -1.751 |
| September 30, 2025 | -1.010 |
| June 30, 2025 | 0.5798 |
| March 31, 2025 | -0.4868 |
| December 31, 2024 | -2.882 |
| September 30, 2024 | -1.017 |
| June 30, 2024 | -1.581 |
| March 31, 2024 | -2.237 |
| December 31, 2023 | -2.637 |
| September 30, 2023 | -4.144 |
| June 30, 2023 | -2.796 |
| March 31, 2023 | -3.355 |
| December 31, 2022 | -0.3524 |
| September 30, 2022 | -5.596 |
| June 30, 2022 | -4.995 |
| March 31, 2022 | -4.124 |
| December 31, 2021 | -4.281 |
| September 30, 2021 | -2.952 |
| June 30, 2021 | -2.160 |
| March 31, 2021 | -1.928 |
| December 31, 2020 | -0.3136 |
| September 30, 2020 | -0.4038 |
| June 30, 2020 | -1.572 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.032 |
| December 31, 2019 | -2.422 |
| September 30, 2019 | -4.255 |
| June 30, 2019 | -2.199 |
| March 31, 2019 | -3.059 |
| December 31, 2018 | -3.401 |
| September 30, 2018 | -1.920 |
| June 30, 2018 | -3.80 |
| March 31, 2018 | -2.032 |
| December 31, 2017 | -2.172 |
| September 30, 2017 | -1.40 |
| June 30, 2017 | -1.20 |
| March 31, 2017 | -1.20 |
| December 31, 2016 | -3.80 |
| September 30, 2016 | -1.80 |
| June 30, 2016 | -2.40 |
| March 31, 2016 | -1.60 |
| December 31, 2015 | -1.60 |
| September 30, 2015 | -2.20 |
| June 30, 2015 | 1.00 |
| March 31, 2015 | -3.80 |
| December 31, 2014 | -9.004 |
| September 30, 2014 | -5.00 |
| June 30, 2014 | -5.00 |
| March 31, 2014 | -5.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5293 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.417M |
| Revenue (Quarterly) | 9.633M |
| Total Expenses (Quarterly) | 14.05M |
| Enterprise Value | 44.46M |
| Gross Profit Margin (Quarterly) | 73.18% |
| Profit Margin (Quarterly) | -45.85% |
| Earnings Yield | -96.55% |
| Normalized Earnings Yield | -90.14 |